Abeona Therapeutics Inc vs Payoneer Global Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Payoneer Global Inc trades at $7.08 (market cap $2.40B). The key difference: Payoneer Global Inc is far larger — about 5.7× Abeona Therapeutics Inc's market cap. Which is the better fit depends on your goals.
| ABEO | PAYO | |
|---|---|---|
Market Cap | $421.19M | $2.40B |
Sector | Health | Technology |
52-Week High | $7.45 | $7.17 |
52-Week Low | $4.17 | $4.27 |
Enterprise Value | $276.10M | $2.14B |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →